Summit Therapeutics PLC (NASDAQ:SMMT)

1.26
Delayed Data
As of Aug 21
 -0.04 / -3.08%
Today’s Change
1.10
Today|||52-Week Range
2.50
+9.57%
Year-to-Date
No recent news for Summit Therapeutics PLC.

Today’s Trading

Previous close1.30
Today’s open1.29
Day’s range1.26 - 1.29
Volume53,782
Average volume (3 months)35,577
Market cap$40.8M
Data as of 4:00pm ET, 08/21/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-294.79%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+72.54%
P/E ratio1.5
Price/Sales0.40
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc+0.03+0.77%
BLPHBellerophon Therapeu...+0.02+3.45%
FBIOPFortress Biotech Inc+0.24+1.14%
MGENMiragen Therapeutics...-0.07-4.96%
Data as of 4:00pm ET, 08/21/2019

Financials

Next reporting dateSeptember 19, 2019
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$57.0M
Annual profit (last year)$10.0M
Net profit margin17.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Glyn Owain Edwards
Chief Operating &
Medical Officer
David Roblin
Corporate headquarters
Abingdon, Oxfordshire

Forecasts